Paclitaxel-eluting stent versus conventional stent in STE-myocardial infarction; angiographic long-term evaluation;Long-term angiographic follow-up after primary PCI for acute myocardial infarction; paclitaxel-eluting stent versus bare metal stent, as performed in the PASSION trial A single blinded, randomized, dual center study

Paclitaxel-eluting stent versus conventional stent in STE-myocardial infarction; angiographic long-term evaluation;Long-term angiographic follow-up after primary PCI for acute myocardial infarction; paclitaxel-eluting stent versus bare metal stent, as performed in the PASSION trial A single blinded, randomized, dual center study - PASSIONATE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30693

Enrollment

300

Registered

2007-02-13

Start date

2007-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arteriosclerosis coronary artery disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Treatment of acute myocardial infarction by primary PCI between 2003 and 2004, and included in the PASSION trial (published Sep 14 2006 in the New Engl J Med)

Exclusion criteria

Exclusion criteria: renal insuffiency at risk for contrast nephropathy (creatinin > 130 mmol/L)

Design outcomes

Primary

Measure	Time frame
A comparison of late angiographic parameters according to initial treatment method, as well as (in a substudy) intravascular ultrasound meaurements.	—

Secondary

Measure	Time frame
Secondary endpoints include cinical endpoints as major adverse cardiovascular events and anginal class.	—

Countries

Netherlands

Outcome results